It’s believed 100,000 people are affected by Familial Hypercholesterolaemia in Australia and most of those remain undiagnosed. This could lead to a significant public health challenge.

How could an increased focus on risk reduction and management help in the primary prevention of heart disease in Australians?

Nearly one in two high-risk people who have already had a cardiovascular event may still not be meeting the recommended target for LDL-C (low-density lipoprotein cholesterol or bad cholesterol).

What is breakthrough cancer pain?

When selecting an appropriate opioid treatment for BTcP, it is important to consider the pharmacokinetic properties of the treatment.

The ‘total pain’ approach outlines four interconnecting factors that influence a patient’s experience of pain